According to the report titled ‘North America Genetic Testing Market Share By Test Type, Application, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, North America genetic testing market is projected to amass USD 15 billion by 2026 and grow substantially during the forecast period.
 

Increasing cases of cancer and genetic disorders coupled with consumer interests in using personalized medicines are positively impacting the growth of North America genetic testing market. In addition, technological advancements such as development of chromosomal arrays and biochip microarrays for early identification as well as treatment of disorders & diseases are contributing  towards the overall market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683084/
 

As per NIH (National Institute of Health), one in every 15,000 children suffer from phenylketonuria annually. Genetic tests are adopted by doctors as well as patients and are easily accessible, which helps prevent uncertainty of genetic aberrations and disorders. The procedure detects chromosomal defects along with highlighted parts on glass slide, further delivering a systematic analysis, thus influencing North America genetic market trends.
 

Based on test type, predictive testing segment of North America genetic testing industry held considerable revenue share in the year 2019 and is projected to expand with 9.5% CAGR over the analysis period. The segment involves identification of gene mutations linked with genetic disorders after birth or later in life.
 

This test offers information regarding hereditary diseases like sickle cell anemia, alpha & beta thalassemia, hemochromatosis, cystic fibrosis, and others, helping patients to take informed decisions regarding their medical treatment. This technique also aids in reducing risk of acquiring genetic disorders, thereby fueling the segmental share.
 

Speaking of application spectrum, the cardiovascular diseases segment of North America genetic testing market was worth USD 680 million in the year 2019. Cardiovascular diseases detection is essential for a patient’s well being as it is lethal in nature. The segmental growth is credited to information about implantation and use of cardiac defibrillator, and heart transplantation or replacement therapy is required, thereby boosting the genetic testing market in North America.
 

From a regional perspective, Canada genetic testing industry is projected to record a CAGR of 9% over the study period. As per Canadian Cancer Society, 220,400 cancer cases were recorded in 2019 in Canada. The country is focusing on spreading awareness regarding genetic testing as well as providing favorable reimbursement policies. Apart from this, the rising healthcare spending is facilitating Canadian genetic testing market share.
 

Major contenders in North America genetic testing market are Stryker Corporation, Integra LifeScience Holdings Corporation, DePuy Synthes, CONMED Corporation, and Acumed LLC among others.